Tumormarker im Perikarderguss bei malignen und nichtmalignen Perikardergüssen View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-06

AUTHORS

K. Karatolios, B. Maisch, S. Pankuweit

ABSTRACT

BACKGROUND: The differential diagnosis of pericardial effusion is often challenging because different etiologies can be discussed. Of particular therapeutic and prognostic importance is the definitive differentiation of malignant pericardial effusion from benign effusions. The definitive diagnosis of malignant pericardial effusion is established by a positive cytological examination of the pericardial fluid. However, pericardial fluid cytology, although specific has variable sensitivity. Tumor markers are often investigated after pericardiocentesis but their utility as an aid for the diagnosis of malignant pericardial effusion is not well established. The aim of this study was to measure the concentrations of the tumor markers CEA, CA 19-9, CA 72-4, SCC and NSE in malignant and non-malignant pericardial effusions and to assess their diagnostic utility in differentiating malignant from benign pericardial effusion. METHODS: We investigated the pericardial fluid of 29 patients with proven malignant pericardial effusion and 25 patients with non-malignant pericardial effusion. The etiology of the pericardial effusion was defined by pericardial cytology, epicardial histology and PCR for cardiotropic viruses from pericardial and epicardial tissue acquired by pericardioscopy. The group with non-malignant pericardial effusion comprised 15 patients with autoreactive effusion and 10 patients with viral pericardial effusion. We analyzed the following tumor markers in the pericardial fluid: carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, carbohydrate antigen (CA) 72-4, squamous cell carcinoma (SCC) antigen and neuron-specific enolase (NSE). RESULTS: Of the tumor markers tested the mean concentrations of the CEA, CA 72-4 and CA 19-9 were significantly higher in malignant pericardial effusions than in non-malignant effusions (CEA 450.66 ±1620.58 µg/l vs. 0.72 ±1.49 µg/l, p<0.001; CA 19-9 1331.31 ±3420.87 kU/l vs. 58.85 ±17.53 kU/l, p=0.04; CA 72-4 707.90 ±2397.55 kU/l vs. 0.48 ±2.40 kU/l, p<0.001). ROC curve analysis showed that pericardial fluid CA 72-4 yielded an area under the curve (AUC) of 0.85 (95% confidence interval 0.74-0.95), followed by CEA with 0.80 (95% confidence interval 0.68-0.92). Pericardial fluid CA 72-4 levels >1.0 kU/l had 72% sensitivity (95% confidence interval 53%-87%) and 96% specificity (95% confidence interval 80%-99.9%) and CA 72-4 levels >2.5 kU/l had 69% sensitivity (95% confidence interval 49%-85%) and 96% specificity (95% confidence interval 80%-99.9%) in differentiating malignant pericardial effusions from effusions due to benign conditions. CONCLUSION: Malignant pericardial effusions are associated with significantly higher pericardial concentrations of the tumor markers CEA, CA 72-4 and CA 19-9. Of the tested tumor markers, measurement of CA 72-4 levels in pericardial fluid offered the best diagnostic accuracy. Based on our data evaluation of every patient with unexplained pericardial effusion and negative pericardial fluid cytology should include the measurement of pericardial fluid CA 72-4 levels. Under these circumstances the elevation of pericardial fluid CA 72-4 levels should include malignancy as a probable diagnosis. More... »

PAGES

290-295

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00059-011-3451-6

DOI

http://dx.doi.org/10.1007/s00059-011-3451-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000619104

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21491120


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pericardial Effusion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsklinikum Gie\u00dfen und Marburg", 
          "id": "https://www.grid.ac/institutes/grid.411067.5", 
          "name": [
            "Klinik f\u00fcr Innere Medizin, Schwerpunkte Kardiologie, Angiologie, Internistische Intensivmedizin und Pr\u00e4vention, Universit\u00e4tsklinikum Giessen und Marburg GmbH, Baldingerstr. 1, 35033, Marburg, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karatolios", 
        "givenName": "K.", 
        "id": "sg:person.0775470565.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775470565.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsklinikum Gie\u00dfen und Marburg", 
          "id": "https://www.grid.ac/institutes/grid.411067.5", 
          "name": [
            "Klinik f\u00fcr Innere Medizin, Schwerpunkte Kardiologie, Angiologie, Internistische Intensivmedizin und Pr\u00e4vention, Universit\u00e4tsklinikum Giessen und Marburg GmbH, Baldingerstr. 1, 35033, Marburg, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maisch", 
        "givenName": "B.", 
        "id": "sg:person.0630132362.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630132362.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsklinikum Gie\u00dfen und Marburg", 
          "id": "https://www.grid.ac/institutes/grid.411067.5", 
          "name": [
            "Klinik f\u00fcr Innere Medizin, Schwerpunkte Kardiologie, Angiologie, Internistische Intensivmedizin und Pr\u00e4vention, Universit\u00e4tsklinikum Giessen und Marburg GmbH, Baldingerstr. 1, 35033, Marburg, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pankuweit", 
        "givenName": "S.", 
        "id": "sg:person.01314066670.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314066670.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0002-9343(78)90800-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005039019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.89.6.2728", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009117544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00059-010-3382-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012362722", 
          "https://doi.org/10.1007/s00059-010-3382-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pcad.2010.06.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017637697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000051366.97361.ea", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025138278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.95.5.1142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026608204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.111.5.1213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029720407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1048749667", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-11335-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048749667", 
          "https://doi.org/10.1007/978-3-642-11335-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-11335-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048749667", 
          "https://doi.org/10.1007/978-3-642-11335-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00059-004-2628-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051503075", 
          "https://doi.org/10.1007/s00059-004-2628-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ehj.2004.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054732432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/euhj.2002.3152", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057075263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/euhj.2002.3328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057075381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2007-984955", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057513214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/15.suppl_c.68", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059574978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460080502000107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077039172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460080502000107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077039172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460089701200302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083217263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460089701200302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083217263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5301/jbm.2008.318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083843720"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-06", 
    "datePublishedReg": "2011-06-01", 
    "description": "BACKGROUND: The differential diagnosis of pericardial effusion is often challenging because different etiologies can be discussed. Of particular therapeutic and prognostic importance is the definitive differentiation of malignant pericardial effusion from benign effusions. The definitive diagnosis of malignant pericardial effusion is established by a positive cytological examination of the pericardial fluid. However, pericardial fluid cytology, although specific has variable sensitivity. Tumor markers are often investigated after pericardiocentesis but their utility as an aid for the diagnosis of malignant pericardial effusion is not well established. The aim of this study was to measure the concentrations of the tumor markers CEA, CA 19-9, CA 72-4, SCC and NSE in malignant and non-malignant pericardial effusions and to assess their diagnostic utility in differentiating malignant from benign pericardial effusion.\nMETHODS: We investigated the pericardial fluid of 29 patients with proven malignant pericardial effusion and 25 patients with non-malignant pericardial effusion. The etiology of the pericardial effusion was defined by pericardial cytology, epicardial histology and PCR for cardiotropic viruses from pericardial and epicardial tissue acquired by pericardioscopy. The group with non-malignant pericardial effusion comprised 15 patients with autoreactive effusion and 10 patients with viral pericardial effusion. We analyzed the following tumor markers in the pericardial fluid: carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, carbohydrate antigen (CA) 72-4, squamous cell carcinoma (SCC) antigen and neuron-specific enolase (NSE).\nRESULTS: Of the tumor markers tested the mean concentrations of the CEA, CA 72-4 and CA 19-9 were significantly higher in malignant pericardial effusions than in non-malignant effusions (CEA 450.66 \u00b11620.58 \u00b5g/l vs. 0.72 \u00b11.49 \u00b5g/l, p<0.001; CA 19-9 1331.31 \u00b13420.87 kU/l vs. 58.85 \u00b117.53 kU/l, p=0.04; CA 72-4 707.90 \u00b12397.55 kU/l vs. 0.48 \u00b12.40 kU/l, p<0.001). ROC curve analysis showed that pericardial fluid CA 72-4 yielded an area under the curve (AUC) of 0.85 (95% confidence interval 0.74-0.95), followed by CEA with 0.80 (95% confidence interval 0.68-0.92). Pericardial fluid CA 72-4 levels >1.0 kU/l had 72% sensitivity (95% confidence interval 53%-87%) and 96% specificity (95% confidence interval 80%-99.9%) and CA 72-4 levels >2.5 kU/l had 69% sensitivity (95% confidence interval 49%-85%) and 96% specificity (95% confidence interval 80%-99.9%) in differentiating malignant pericardial effusions from effusions due to benign conditions.\nCONCLUSION: Malignant pericardial effusions are associated with significantly higher pericardial concentrations of the tumor markers CEA, CA 72-4 and CA 19-9. Of the tested tumor markers, measurement of CA 72-4 levels in pericardial fluid offered the best diagnostic accuracy. Based on our data evaluation of every patient with unexplained pericardial effusion and negative pericardial fluid cytology should include the measurement of pericardial fluid CA 72-4 levels. Under these circumstances the elevation of pericardial fluid CA 72-4 levels should include malignancy as a probable diagnosis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00059-011-3451-6", 
    "inLanguage": [
      "de"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1087175", 
        "issn": [
          "0340-9937", 
          "1615-6692"
        ], 
        "name": "Herz", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "name": "Tumormarker im Perikarderguss bei malignen und nichtmalignen Perikarderg\u00fcssen", 
    "pagination": "290-295", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "02f2a26c9110cca6e5846cc39e777415968352e9571a492c2750d1685092a73f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21491120"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7801231"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00059-011-3451-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000619104"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00059-011-3451-6", 
      "https://app.dimensions.ai/details/publication/pub.1000619104"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000485.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00059-011-3451-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00059-011-3451-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00059-011-3451-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00059-011-3451-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00059-011-3451-6'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      21 PREDICATES      58 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00059-011-3451-6 schema:about N0ff2df25a3e240be94d7277cd32c64d6
2 N20b707e4bfb040bab04e15944f5d7cee
3 N2dca4588620a4cc28bfdcc58cf9fc156
4 N44eb0d4abc2a49a19200430a15bad199
5 N4cae7c8527994fa98215651322e8704f
6 N521ccbf5249f4bf5b4e3c2868186ff3a
7 N7cac277dbbe34c859162570e1bbcd06e
8 N9b9688f54ca145689769621c3ef352ae
9 Na64fe751141848f386cf179ab110f626
10 Nec68cbcc5a7e49659fd3d2d80c37d378
11 Nfe3133ed51d14240b4d0e6038f237f03
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N7fa7aa42c9d54e8b87c4bfe67998d545
15 schema:citation sg:pub.10.1007/978-3-642-11335-2
16 sg:pub.10.1007/s00059-004-2628-7
17 sg:pub.10.1007/s00059-010-3382-7
18 https://app.dimensions.ai/details/publication/pub.1048749667
19 https://doi.org/10.1016/0002-9343(78)90800-8
20 https://doi.org/10.1016/j.ehj.2004.02.002
21 https://doi.org/10.1016/j.pcad.2010.06.003
22 https://doi.org/10.1053/euhj.2002.3152
23 https://doi.org/10.1053/euhj.2002.3328
24 https://doi.org/10.1055/s-2007-984955
25 https://doi.org/10.1093/eurheartj/15.suppl_c.68
26 https://doi.org/10.1161/01.cir.0000051366.97361.ea
27 https://doi.org/10.1161/01.cir.89.6.2728
28 https://doi.org/10.1177/172460080502000107
29 https://doi.org/10.1177/172460089701200302
30 https://doi.org/10.1378/chest.111.5.1213
31 https://doi.org/10.1378/chest.95.5.1142
32 https://doi.org/10.5301/jbm.2008.318
33 schema:datePublished 2011-06
34 schema:datePublishedReg 2011-06-01
35 schema:description BACKGROUND: The differential diagnosis of pericardial effusion is often challenging because different etiologies can be discussed. Of particular therapeutic and prognostic importance is the definitive differentiation of malignant pericardial effusion from benign effusions. The definitive diagnosis of malignant pericardial effusion is established by a positive cytological examination of the pericardial fluid. However, pericardial fluid cytology, although specific has variable sensitivity. Tumor markers are often investigated after pericardiocentesis but their utility as an aid for the diagnosis of malignant pericardial effusion is not well established. The aim of this study was to measure the concentrations of the tumor markers CEA, CA 19-9, CA 72-4, SCC and NSE in malignant and non-malignant pericardial effusions and to assess their diagnostic utility in differentiating malignant from benign pericardial effusion. METHODS: We investigated the pericardial fluid of 29 patients with proven malignant pericardial effusion and 25 patients with non-malignant pericardial effusion. The etiology of the pericardial effusion was defined by pericardial cytology, epicardial histology and PCR for cardiotropic viruses from pericardial and epicardial tissue acquired by pericardioscopy. The group with non-malignant pericardial effusion comprised 15 patients with autoreactive effusion and 10 patients with viral pericardial effusion. We analyzed the following tumor markers in the pericardial fluid: carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, carbohydrate antigen (CA) 72-4, squamous cell carcinoma (SCC) antigen and neuron-specific enolase (NSE). RESULTS: Of the tumor markers tested the mean concentrations of the CEA, CA 72-4 and CA 19-9 were significantly higher in malignant pericardial effusions than in non-malignant effusions (CEA 450.66 ±1620.58 µg/l vs. 0.72 ±1.49 µg/l, p<0.001; CA 19-9 1331.31 ±3420.87 kU/l vs. 58.85 ±17.53 kU/l, p=0.04; CA 72-4 707.90 ±2397.55 kU/l vs. 0.48 ±2.40 kU/l, p<0.001). ROC curve analysis showed that pericardial fluid CA 72-4 yielded an area under the curve (AUC) of 0.85 (95% confidence interval 0.74-0.95), followed by CEA with 0.80 (95% confidence interval 0.68-0.92). Pericardial fluid CA 72-4 levels >1.0 kU/l had 72% sensitivity (95% confidence interval 53%-87%) and 96% specificity (95% confidence interval 80%-99.9%) and CA 72-4 levels >2.5 kU/l had 69% sensitivity (95% confidence interval 49%-85%) and 96% specificity (95% confidence interval 80%-99.9%) in differentiating malignant pericardial effusions from effusions due to benign conditions. CONCLUSION: Malignant pericardial effusions are associated with significantly higher pericardial concentrations of the tumor markers CEA, CA 72-4 and CA 19-9. Of the tested tumor markers, measurement of CA 72-4 levels in pericardial fluid offered the best diagnostic accuracy. Based on our data evaluation of every patient with unexplained pericardial effusion and negative pericardial fluid cytology should include the measurement of pericardial fluid CA 72-4 levels. Under these circumstances the elevation of pericardial fluid CA 72-4 levels should include malignancy as a probable diagnosis.
36 schema:genre research_article
37 schema:inLanguage de
38 schema:isAccessibleForFree false
39 schema:isPartOf N40826c4792f24d4c9000c40c81246b90
40 N7e55140cc9bf494b981a58ca0ad709f8
41 sg:journal.1087175
42 schema:name Tumormarker im Perikarderguss bei malignen und nichtmalignen Perikardergüssen
43 schema:pagination 290-295
44 schema:productId N55b5e5b29b3f4b9794d633d4e5f0772d
45 N6058ae276b124b2f9af21b75838ce906
46 Na3b46c9fef5f491dbfe23f1515c16c62
47 Nce0518324c844999a22623b61a367ae5
48 Nd194018c935c499f8d18c81b86e431c0
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000619104
50 https://doi.org/10.1007/s00059-011-3451-6
51 schema:sdDatePublished 2019-04-10T18:14
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N2696903ba29f413fb40bed7f6330a2ab
54 schema:url http://link.springer.com/10.1007/s00059-011-3451-6
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N0ff2df25a3e240be94d7277cd32c64d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Female
60 rdf:type schema:DefinedTerm
61 N20b707e4bfb040bab04e15944f5d7cee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Pericardial Effusion
63 rdf:type schema:DefinedTerm
64 N2696903ba29f413fb40bed7f6330a2ab schema:name Springer Nature - SN SciGraph project
65 rdf:type schema:Organization
66 N2dca4588620a4cc28bfdcc58cf9fc156 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Adult
68 rdf:type schema:DefinedTerm
69 N38ff877e77104965bab4cae35177ff6a rdf:first sg:person.01314066670.18
70 rdf:rest rdf:nil
71 N40826c4792f24d4c9000c40c81246b90 schema:issueNumber 4
72 rdf:type schema:PublicationIssue
73 N44eb0d4abc2a49a19200430a15bad199 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Reproducibility of Results
75 rdf:type schema:DefinedTerm
76 N4cae7c8527994fa98215651322e8704f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Biomarkers, Tumor
78 rdf:type schema:DefinedTerm
79 N521ccbf5249f4bf5b4e3c2868186ff3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Male
81 rdf:type schema:DefinedTerm
82 N55b5e5b29b3f4b9794d633d4e5f0772d schema:name readcube_id
83 schema:value 02f2a26c9110cca6e5846cc39e777415968352e9571a492c2750d1685092a73f
84 rdf:type schema:PropertyValue
85 N6058ae276b124b2f9af21b75838ce906 schema:name doi
86 schema:value 10.1007/s00059-011-3451-6
87 rdf:type schema:PropertyValue
88 N75fe521f54504c63b4cb781e9a5977b5 rdf:first sg:person.0630132362.75
89 rdf:rest N38ff877e77104965bab4cae35177ff6a
90 N7cac277dbbe34c859162570e1bbcd06e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Aged
92 rdf:type schema:DefinedTerm
93 N7e55140cc9bf494b981a58ca0ad709f8 schema:volumeNumber 36
94 rdf:type schema:PublicationVolume
95 N7fa7aa42c9d54e8b87c4bfe67998d545 rdf:first sg:person.0775470565.27
96 rdf:rest N75fe521f54504c63b4cb781e9a5977b5
97 N9b9688f54ca145689769621c3ef352ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 Na3b46c9fef5f491dbfe23f1515c16c62 schema:name dimensions_id
101 schema:value pub.1000619104
102 rdf:type schema:PropertyValue
103 Na64fe751141848f386cf179ab110f626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Humans
105 rdf:type schema:DefinedTerm
106 Nce0518324c844999a22623b61a367ae5 schema:name pubmed_id
107 schema:value 21491120
108 rdf:type schema:PropertyValue
109 Nd194018c935c499f8d18c81b86e431c0 schema:name nlm_unique_id
110 schema:value 7801231
111 rdf:type schema:PropertyValue
112 Nec68cbcc5a7e49659fd3d2d80c37d378 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Sensitivity and Specificity
114 rdf:type schema:DefinedTerm
115 Nfe3133ed51d14240b4d0e6038f237f03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Heart Neoplasms
117 rdf:type schema:DefinedTerm
118 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
119 schema:name Medical and Health Sciences
120 rdf:type schema:DefinedTerm
121 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
122 schema:name Oncology and Carcinogenesis
123 rdf:type schema:DefinedTerm
124 sg:journal.1087175 schema:issn 0340-9937
125 1615-6692
126 schema:name Herz
127 rdf:type schema:Periodical
128 sg:person.01314066670.18 schema:affiliation https://www.grid.ac/institutes/grid.411067.5
129 schema:familyName Pankuweit
130 schema:givenName S.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314066670.18
132 rdf:type schema:Person
133 sg:person.0630132362.75 schema:affiliation https://www.grid.ac/institutes/grid.411067.5
134 schema:familyName Maisch
135 schema:givenName B.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630132362.75
137 rdf:type schema:Person
138 sg:person.0775470565.27 schema:affiliation https://www.grid.ac/institutes/grid.411067.5
139 schema:familyName Karatolios
140 schema:givenName K.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775470565.27
142 rdf:type schema:Person
143 sg:pub.10.1007/978-3-642-11335-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048749667
144 https://doi.org/10.1007/978-3-642-11335-2
145 rdf:type schema:CreativeWork
146 sg:pub.10.1007/s00059-004-2628-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051503075
147 https://doi.org/10.1007/s00059-004-2628-7
148 rdf:type schema:CreativeWork
149 sg:pub.10.1007/s00059-010-3382-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012362722
150 https://doi.org/10.1007/s00059-010-3382-7
151 rdf:type schema:CreativeWork
152 https://app.dimensions.ai/details/publication/pub.1048749667 schema:CreativeWork
153 https://doi.org/10.1016/0002-9343(78)90800-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005039019
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.ehj.2004.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054732432
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.pcad.2010.06.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017637697
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1053/euhj.2002.3152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057075263
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1053/euhj.2002.3328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057075381
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1055/s-2007-984955 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057513214
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1093/eurheartj/15.suppl_c.68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059574978
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1161/01.cir.0000051366.97361.ea schema:sameAs https://app.dimensions.ai/details/publication/pub.1025138278
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1161/01.cir.89.6.2728 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009117544
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1177/172460080502000107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077039172
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1177/172460089701200302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083217263
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1378/chest.111.5.1213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029720407
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1378/chest.95.5.1142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026608204
178 rdf:type schema:CreativeWork
179 https://doi.org/10.5301/jbm.2008.318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083843720
180 rdf:type schema:CreativeWork
181 https://www.grid.ac/institutes/grid.411067.5 schema:alternateName Universitätsklinikum Gießen und Marburg
182 schema:name Klinik für Innere Medizin, Schwerpunkte Kardiologie, Angiologie, Internistische Intensivmedizin und Prävention, Universitätsklinikum Giessen und Marburg GmbH, Baldingerstr. 1, 35033, Marburg, Deutschland
183 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...